AboutContact us
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
From Iron Dome to Arrow missiles, unpaid bills accumulate in Israel’s defense sector
2
The 50 most promising Israeli startups - 2026
3
“With Armis, ServiceNow is positioned to build the largest cyber business in the world”
4
WorldQuant billionaire launches Israeli deep-tech venture arm
5
Crypto unicorn MoonPay acquires Israeli security startup Sodot for $100 million
More news

Remepy

6 stories about Remepy
Remepy founders

Merck KGaA and Remepy partner to test ‘Hybrid Drugs’ model

28.04.26|Meir Orbach
Collaboration explores combining medication with app-based therapies in rare tumor programs. 
כנס צמיחה נפתלי בנט ראש הממשלה לשעבר ו ד"ר מיכל צור מייסדת ומנכלית משותפת Remepy

Bennett: "The government's stalling strategy will lead us to existential danger"

27.06.24|Maya Nahum Shahal
The former prime minister, who serves as a director at Remepy, spoke at the Growth Conference of Calcalist and Mizrahi-Tefahot with the company’s founder and joint CEO, Dr. Michal Tsur. He called for increasing the effort to defeat Hamas in Gaza, stating, "And if there are considerations that do not allow this, then we can go to a deal." Bennett expressed optimism regarding Israel's economy, even though "there are some problems with the way it is being managed."
מימין שחר קרני מייסד משותף ומנכ"ל PhenoTA וד"ר מיכל צור מייסדת ומנכ"לית Remepy

"Founding a company during a crisis for Israel and its people is a matter of pride"

28.05.24|Maayan Manela
Dr. Michal Tsur from Remepy and Shahar Karny from PhenoTA both work in the Health Tech field and talked about how to solve problems. The meeting was held as part of the Growth+ project by Calcalist and Poalim Tech, in which one-on-one counseling and mentoring sessions are held between experienced entrepreneurs and early-stage start-up companies
אור שובל אמיר עמדי ו מיכל צור רמפי

Remepy raises $10 million Seed round to bring first hybrid drug to market

01.05.24|Meir Orbach
The Israeli startup’s new hybrid drugs combine traditional drugs with its “digital molecules.” Digital molecules are therapeutic interventions that trigger physiological effects through the brain
מוסף שבועי 22.2.24 היזמית מיכל צור

"Until there is unity and equality here, Israel has no chance"

22.02.24|Sophie Shulman
At night, serial entrepreneur Michal Tsur doesn’t sleep, worrying about her son fighting in the army. During the day, she is busy with her third startup, Remepy, and dreaming of a new country - the same country for which she took to the streets as one of the leaders of last year’s protest against the judicial reform
נפתלי בנט ו מיכל צור

Naftali Bennett and Michal Tsur unite at Remepy: Former PM joins Board for hybrid drug endeavor

14.02.24|Sophie Shulman
This is the third high-tech board Bennett has joined since he left politics, previously joining AI cyber company Lasoo and quantum computing startup Quantum Source. Tsur and Bennett founded Cyota in 1999 together with Ben Enosh and Lior Golan and sold it to RSA Security in 2005 for $145 million